Fast Field Cycling imaging of kidney disease

  • Research type

    Research Study

  • Full title

    Investigating a novel molecular imaging technique, Fast Field-Cycling, for kidney health and disease

  • IRAS ID

    302880

  • Contact name

    Simon Sawhney

  • Contact email

    simon.sawhney@abdn.ac.uk

  • Sponsor organisation

    University of Aberdeen and NHS Grampian

  • Clinicaltrials.gov Identifier

    N/A, N/A

  • Duration of Study in the UK

    0 years, 6 months, 28 days

  • Research summary

    The kidneys are vital organs responsible for clearance of toxins in the human body. The kidneys age over time and this ageing process is complex, involving changes both to their structure and function, and can be accelerated by disease processes. Without an invasive biopsy procedure, it is often difficult to distinguish between age-related damage from active disease, that could be modified with treatment. Even with a biopsy however, diseases are often patchy and can be overlooked if missed by the biopsy sample procedure. Alternative imaging approaches have limited ability to differentiate between modifiable and non-modifiable disease processes. Our team, based at the University of Aberdeen, has developed a unique magnetic imaging technology, Fast Field-Cycling (FFC) imaging. FFC derives from conventional MRI scanners but has the ability to change its magnetic field strength during a scan. This is equivalent to having many MRI scanners in one device and allows completely new analyses of the behaviour of tissue remodelling to pathological processes, from millimetres to nanometres. This information is invisible to standard MRI scanners. If this scanner shows that it is effective in monitoring kidney disease then this would contribute to evidence from previous studies in cancer and stroke promoting the need to develop a new scanner that could be used clinically in the future.

  • REC name

    North of Scotland Research Ethics Committee 2

  • REC reference

    22/NS/0096

  • Date of REC Opinion

    18 Jul 2022

  • REC opinion

    Favourable Opinion